You are here

Petrusné Miltényi Zsófia

Petrusné Miltényi Zsófia

Petrusné Miltényi Zsófia
Name: Petrusné Miltényi Zsófia
Other profiles: Google Scholar
Profession: physician, haematologist

Publication list

Uploaded publications:
142
Publications in DEA:
137
OA:
31
Date range:
1998-2022
2022
  1. Husi, K., Pinczés, L., Fejes, Z., Nagy, B., Illés, Á., Miltényi, Z.: Combined prognostic role of TARC and interim 18F-FDG PET/CT in patients with Hodgkin lymphoma-real world observational study.
    Hell. J. Nucl. Med. 25 (2), 125-131, 2022.
    Journal metrics:
    Q4 Medicine (miscellaneous) (2021)
    Q4 Radiology, Nuclear Medicine and Imaging (2021)
  2. Madarász, K., Mótyán, J., Bedekovics, J., Miltényi, Z., Ujfalusi, A., Méhes, G., Mokánszki, A.: Deep Molecular and In Silico Protein Analysis of p53 Alteration in Myelodysplastic Neoplasia and Acute Myeloid Leukemia.
    Cells. 11 (21), 1-23, 2022.
    Journal metrics:
    Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2021)
  3. László, I., Berhés, M., Tisza, K., Miltényi, Z., Balázsfalvi, N., Vaskó, A., Asztalos, L., Kertész, A., Fábián, Á., Kappelmayer, J., Fülesdi, B.: The prognostic value of laboratory parameters referring to hemopoietic stress in patients with COVID-19: a single center experience.
    Signa Vitae. [Epub ahead of print]2022.
    Journal metrics:
    Q3 Critical Care and Intensive Care Medicine (2021)
    Q3 Emergency Medicine (2021)
2021
  1. Pinczés, L., Szabó, R., Miltényi, Z., Illés, Á.: The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma.
    Int. J. Hematol. 113 (2), 175-182, 2021.
    Journal metrics:
    Q2 Hematology
  2. Simon, Z., Virga, B., Pinczés, L., Méhes, G., Miltényi, Z., Barna, S., Szabó, R., Illés, Á.: Transition Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma- Our Histopathological and Clinical Experience With Patients With Intermediate Lymphoma.
    Pathol. Oncol. Res. 27 1-7, 2021.
    Journal metrics:
    Q3 Cancer Research
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q2 Pathology and Forensic Medicine
2020
  1. Pinczés, L., Szabó, R., Illés, Á., Földeák, D., Piukovics, K., Szomor, Á., Gopcsa, L., Miltényi, Z.: Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma.
    Ann. Hematol. 99 2385-2392, 2020.
    Journal metrics:
    Q2 Hematology
    Q1 Medicine (miscellaneous)
2019
  1. Méhes, G., Matolay, O., Beke, L., Czenke, M., Jóna, Á., Miltényi, Z., Illés, Á., Bedekovics, J.: Hypoxia related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma.
    Histopathology. 74 (5), 699-708, 2019.
    Journal metrics:
    Q1 Histology
    Q1 Medicine (miscellaneous)
    Q1 Pathology and Forensic Medicine
  2. Matolay, O., Méhes, G., Beke, L., Czenke, M., Jóna, Á., Miltényi, Z., Illés, Á., Bedekovics, J.: Tracking the cluster of differentiation 30 and carbonic anhydrase IX enzyme expression pattern in classical Hodgkin lymphoma cases.
    In: 15th Warsaw International Medical Congress Abstract Book, The Students' Scientific Association of the Medical University of Warsaw, Varsó, 228-229, 2019. ISBN: 9788376374888
2018
  1. Kenyeres, A., Simon, Z., Batár, P., Gergely, L., Jóna, Á., Magyari, F., Miltényi, Z., Reményi, G., Szász, R., Váróczy, L., Barna, S., Garai, I., Illés, Á.: A PET-CT vizsgálatokkal szerzett tapasztalataink follicularis lymphomában.
    In: Malygnus Lymphoma Konferencia, Magyar Hematológiai és Transzfúziológiai Társaság, Debrecen, 53, 2018.
  2. Magyari, F., Ivánka, T., Simon, Z., Miltényi, Z., Kósa, K., Illés, Á.: Kognitív Diszfunkció a Hodgkin-lymphoma kezelése után.
    In: Malygnus Lymphoma Konferencia, Magyar Hematológiai és Transzfúziológiai Társaság, Debrecen, 63, 2018.
  3. Kárai, B., Miltényi, Z., Gergely, L., Széles, M., Kappelmayer, J., Hevessy, Z.: The impact of delayed sample handling and type of anticoagulant on the interpretation of dysplastic signs detected by flow cytometry.
    Biochem Med (Zagreb). 28 (2), 1-13, 2018.
    Journal metrics:
    Q2 Biochemistry (medical)
    Q2 Clinical Biochemistry
  4. Pinczés, L., Miltényi, Z., Illés, Á.: Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.
    J. Cancer Res. Clin. Oncol. 144 (5), 935-943, 2018.
    Journal metrics:
    Q2 Cancer Research
    Q1 Medicine (miscellaneous)
    Q2 Oncology
2017
  1. Kárai, B., Bedekovics, J., Miltényi, Z., Gergely, L., Szerafin, L., Ujfalusi, A., Kappelmayer, J., Hevessy, Z.: A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
    Int. J. Lab. Hematol. 39 (6), 577-584, 2017.
    Journal metrics:
    Q2 Biochemistry (medical)
    Q2 Clinical Biochemistry
    Q2 Hematology
    Q2 Medicine (miscellaneous)
  2. Magyari, F., Kósa, K., Berecz, R., Illés, A., Miltényi, Z., Simon, Z., Illés, Á.: Employment status and health related quality of life among Hodgkin-lymphoma survivors'- results based on data from a major treatment center in Hungary.
    Health Qual. Life Outcomes. 15 (1), 1-9, 2017.
    Journal metrics:
    Q1 Medicine (miscellaneous)
    Q1 Public Health, Environmental and Occupational Health
  3. Illés, Á., Simon, Z., Udvardy, M., Magyari, F., Jóna, Á., Miltényi, Z.: Így kezeljük az autológ őssejt-transzplantáció után kiújult Hodgkin-lymphomát.
    Orvosi Hetilap. 158 (34), 1338-1345, 2017.
    Journal metrics:
    Q4 Medicine (miscellaneous)
  4. Molnár, Z., Pinczés, L., Piukovics, K., Istenes, I., Wolf, K., Csukly, Z., Szomor, Á., Illés, Á., Miltényi, Z.: Relabáló/refrakter Hodgkin-lymphoma brentuximab vedotin kezelése.
    Orvosi Hetilap. 158 (41), 1630-1634, 2017.
    Journal metrics:
    Q4 Medicine (miscellaneous)
2016
Show all
updated: 2023-03-19, 01:37

SCImago quartiles of
scientific journal articles

Number of scientific articles: 99
Q1/D1 3 (3%)
Q1 16 (16.2%)
Q2 18 (18.2%)
Q3 19 (19.2%)
Q4 10 (10.1%)
N/A 36 (36.4%)
-
OK

SCImago subject areas and categories

Medicine (60)
Medicine (miscellaneous) (47)
Oncology (16)
Hematology (15)
Pathology and Forensic Medicine (8)
Biochemistry (medical) (2)
Critical Care and Intensive Care Medicine (1)
Emergency Medicine (1)
Gastroenterology (1)
Histology (1)
Immunology and Allergy (1)
Neurology (clinical) (1)
Pharmacology (medical) (1)
Public Health, Environmental and Occupational Health (1)
Radiology, Nuclear Medicine and Imaging (1)
Rheumatology (1)
Biochemistry, Genetics and Molecular Biology (16)
Cancer Research (12)
Biochemistry, Genetics and Molecular Biology (miscellaneous) (2)
Clinical Biochemistry (2)
Agricultural and Biological Sciences (1)
Agricultural and Biological Sciences (miscellaneous) (1)
Immunology and Microbiology (1)
Immunology (1)
Neuroscience (1)
Neurology (1)
Pharmacology, Toxicology and Pharmaceutics (1)
Pharmacology (1)
Toxicology (1)

Genre chart

Year chart

Language chart

Journals

Show more

iDEa co-authors

Show more

Other co-authors

Show more
Balázsfalvi Norbert